Pura Vida Investments’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Pura Vida Investments’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,423	Closed	-$143K	–	263
2022 Q2	$143K	Hold	5,423	–	–	0.01%	197
2022 Q1	$434K	Buy	5,423 +15	+0.3%	+$1.85K	0.01%	206
2021 Q4	$1.1M	Buy	5,408 +2,418	+81%	+$603K	0.04%	175
2021 Q3	$967K	Sell	2,990 -7,712	-72%	-$2.25M	0.03%	221
2021 Q2	$2.78M	Buy	10,702 +3,226	+43%	+$983K	0.09%	143
2021 Q1	$2.89M	Buy	7,476 +275	+4%	+$111K	0.08%	145
2020 Q4	$3.01M	Buy	+7,201	New	+$2.27M	0.11%	126

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Pura Vida Investments's VINC Position: Q3 2022 in Review

Pura Vida Investments sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2022, closing a stake of 5,423 shares — an estimated $143K sold.

Pura Vida Investments first reported a position in VINC in Q4 2020 and held it in 7 quarters. The position peaked at $3.01M in Q4 2020. 42 funds tracked by Wall St. Rank hold VINC as of Q3 2022.

Pura Vida Investments reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Pura Vida Investments sold 5,423 Vincerx Pharma, Inc. Common Stock shares in Q3 2022, an estimated $143K.
Pura Vida Investments first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Pura Vida Investments's Vincerx Pharma, Inc. Common Stock position peaked at $3.01M in Q4 2020.
42 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.